Congratulations to our Bone Marrow Transplant (BMT) team! The Cigna LifeSOURCE Transplant Network has rated the WVU Cancer Institute Osborn Hematopoietic Malignancy and Transplantation Program a Program of Excellence once again. Cigna, an insurance company WVU contracts with that allows patients to be transplanted at our facility, based the excellence designation on specific criteria and guidelines, including number and types of transplants, patient survival and disease status. “This validates that our program provides superior care,” says Sonia Leadmon, oncology quality coordinator at the Cancer Institute’s Mary Babb Randolph Cancer Center. WVU has been rated a Cigna Program of Excellence every year since 2014 and has received excellence designations from several other insurance companies for its BMT program.
The WVU Cancer Institute will hold its Annual DeLynn Lecture with Maura L. Gillison, MD, PhD, who will lecture on HPV and the Host Genome, at 4 pm on Tuesday, Sept. 4, in the WVU Health Sciences Center's Fukushima Auditorium (room 1901). A Q&A session will follow the lecture. The event is free and open to the public. For those who cannot attend, the event also will be webcast.
Four WVU Medicine hospitals have been recognized by U.S. News & World Report as part of its 2018-19 Best Hospitals in the United States.
The WVU School of Public Health will kick off its 2018-2019 Dean’s Colloquium Series with a discussion about the future of public health education.